In agreement with multi-biomarker data from other HCC cohorts, we find complex multi-biomarker expression profiles, despite a BCLC A-B diagnosis, with most positive profiles containing AFP-L3+/DCP+. The gene discussed is ACE; the disease is hepatocellular carcinoma.